Article Text

Download PDFPDF
Incidence of anti-Der f 2 and anti-Zen 1-specific immunoglobulin E antibodies in atopic dogs from South-East England
  1. Anita Patel, BVM DVD FRCVS1,
  2. Cathy F Curtis, BVetMed DVD MRCVS2 and
  3. Rosario Cerundolo, DVM Cert VD DipECVD MRCVS3
  1. 1 Dermatology Referrals, Warlingham, UK
  2. 2 Dermatology Referral Service, Ware, UK
  3. 3 Dick White Referrals, Station Farm, London Road, Six Mile Bottom, Suffolk CB8 0UH, UK
  1. E-mail for correspondence; anita{at}


Recent studies from North America and continental Europe have reported Zen 1 as a major allergen in atopic dogs, and Der f 2 as a minor allergen. In contrast, Der f 2 is considered a major allergen in Japan. In this study, allergen-specific IgE against Der f 2, Zen 1 and crude Dermatophagoides farinae (DF) was determined using ELISA assays in English atopic dogs. Serum samples were obtained from 59 dogs with non-seasonal atopic dermatitis. ELISA assays using horseradish peroxidase-labelled anti-dog IgE monoclonal antibody (Bethyl; A40-125P) and recombinant Der f 2 (Zenoaq), natural Zen 1 (Zenoaq) and DF extract (Greer Laboratories; North Carolina) were performed by Zenoaq, Fukushima, Japan. The mean optical density (OD) of each sample was determined and the cut-off value was calculated from OD readings obtained from four healthy control dogs. Der f 2, Zen 1 and DF-specific IgE antibodies were found in the serum samples taken from 57 (97 per cent), 45 (76 per cent) and 47 (80 per cent) atopic dogs, respectively, suggesting that both Zen 1 and Der f 2 are ‘major allergens’ in the South-East England.

  • atopic dogs
  • Der f 2
  • Zen 1
  • Dermatophagoides farinae
View Full Text

Statistics from


  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.